Seneca House Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Seneca House Advisors's PFE Position: Q3 2023 in Review
Seneca House Advisors sold out of Pfizer (PFE) in Q3 2023, closing a stake of 6,157 shares — an estimated $226K sold.
Seneca House Advisors first reported a position in PFE in Q3 2018 and held it in 20 quarters. The position peaked at $864K in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.
- Seneca House Advisors reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
- Seneca House Advisors sold 6,157 Pfizer shares in Q3 2023, an estimated $226K.
- Seneca House Advisors first reported a position in Pfizer in Q3 2018 and held it in 20 quarters.
- Seneca House Advisors's Pfizer position peaked at $864K in Q4 2021.
- 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.
Based on Seneca House Advisors's 13F filing for Q3 2023, filed 13 Oct 2023.